Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Salusin alpha ELISA Kit (AC2873)
Cat.#: ASET-1462
Specifications
Description Human Salusin alpha ELISA Kit is a competitive Enzyme-Linked Immunosorbent Assay (cELISA) designed for the in vitro quantitative determination of human Salusin alpha concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 46.875 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 78.125-5000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2143 Human Ephrin A3 ELISA Kit (AC3554) Quantitative inquiry ASET-1677 Human Cathepsin G ELISA Kit (AC3088) Quantitative inquiry ASET-1504 Human beta Catenin ELISA Kit (AC2915) Quantitative inquiry ASET-2038 Human ABCG1 ELISA Kit (AC3449) Quantitative inquiry ASET-1496 Porcine Neuropeptide Y ELISA Kit (AC2907) Quantitative inquiry ASET-2317 Rat Ghrelin ELISA Kit (AC3728) Quantitative inquiry ASET-2337 Human GLP1 ELISA Kit (AC3748) Quantitative inquiry ASET-1916 Human Lgi4 ELISA Kit (AC3327) Quantitative inquiry ASET-1543 Mouse TRPV1 ELISA Kit (AC2954) Quantitative inquiry ASET-2328 Human EPHA10 ELISA Kit (AC3739) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
We are committed to accelerating progress in stroke research and drug development.
Copyright © Ace Therapeutics. All rights reserved.0Inquiry Basket